BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 2015

View Archived Issues

Remotely regulated gene exression system devised to study disease

Read More

New NaV1.7 inhibitor identified for the treatment of pain

Read More

Sigma-Tau products granted FDA orphan status

Read More

Elafin shows potential as a biomarker to distinguish GVHD from EM

Read More

Researchers identify INSM1 as a sensitive marker of MCC

Read More

FDA gives ganaxolone orphan status for PCDH19 female epilepsy

Read More

University of Illinois patent describes new antimicrobials

Read More

Bristol-Myers Squibb presents PD-1/PD-L1 interaction inhibitors

Read More

Oxford Pharmascience reports topline data from pilot study of OXPzero Naproxen

Read More

Toray describes highly potent alpha1L-adrenoceptor agonists

Read More

100,000 Genomes Project aims to accelerate the development of new diagnostics and treatments

Read More

Novel GPBAR1 agonists synthesized for the treatment of diabetes and metabolic syndrome

Read More

ZeClinics seeks investment to develop zebra fish-based ZeOncoTest

Read More

Shire and Cincinnati Children's Hospital Medical Center to collaborate on rare disease therapies

Read More

Aldeyra Therapeutics starts phase II trial of NS-2 for non-infectious anterior uveitis

Read More

Japanese approval for Lenvima for unresectable thyroid cancer

Read More

Aduro BioTech cancer vaccine given orphan status for mesothelioma

Read More

Avalanche Biotechnologies and University of Washington collaborate to treat color blindness

Read More

Apceth begins phase II trial of engineered cell therapy to treat gastrointestinal cancer

Read More

Positive outcome from European decentralized procedure for approval of Soolantra for rosacea

Read More

Synflorix obtained Japanese approval as a pediatric pneumococcal conjugate vaccine

Read More

AG-348 assigned orphan status for pyruvate kinase deficiency

Read More

Aurigene discloses PD-1 inhibitors

Read More

Medivir present HCV polymerase NS5B inhibitors

Read More

Korean researchers describe new HGFR inhibtors

Read More

Genfit releases topline data from phase IIb study of GFT-505 for NASH

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 4, 2026.
  • Pancreas 3D hologram

    ASCO 2026: A revolution in pancreatic cancer

    BioWorld
    At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 2, 2026
  • Liver over digital lens background

    EASL 2026: Emerging liver disease targets to watch

    BioWorld
    At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
  • Bispecific antibodies with heavy chain in green and pink, light chain in blue and yellow

    ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out

    BioWorld
    Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing